Patients taking Trulicity should be aware of red flag features that may indicate serious underlying complications or the need for treatment adjustment
Rungby has received personal honoraria for consulting, lectures, and/or for advisory board participation within the last 36 months from AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Janssen-Cilag, Merck Sharp & Dohme, Novo Nordisk, and Sanofi-Aventis and has received unrestricted research grants from Novo Nordisk and Merck
Van Woert MH, Mueller PS, Ambani LM, Rathey U
The dosing used in successful bone healing studies typically ranged from 0.01 mg/kg to 0.01 mg/kg body weight
The November 16 front-page feature in The Washington Post , The surprising new use for GLP-1s: Alcohol and drug addiction, highlights Carons pilot program treating more than 130 patients with promising early results